Cyclenium Pharma Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
5
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Cyclenium Pharma General Information
Description
Operator of a pharmaceutical research company intended to develop macrocyclic drugs for oncology, infectious diseases and pain. The company aims at exploiting its next-generation CMRT macrocyclic drug discovery technology to identify novel small-molecule therapeutics for difficult disease targets in areas of unsatisfied medical need, enabling doctors to find useful and innovative drugs for not-so-common diseases.
Contact Information
Website
www.cyclenium.com(Operating Subsidiary)
Corporate Office
- 7171 Frederick Banting
- Montreal, Quebec H4S 1Z9
- Canada
Corporate Office
- 7171 Frederick Banting
- Montreal, Quebec H4S 1Z9
- Canada
Cyclenium Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Cyclenium Pharma Comparisons
Industry
Financing
Details
Cyclenium Pharma Competitors (53)
One of Cyclenium Pharma’s 53 competitors is Pfizer Pakistan, a Corporation company based in Karachi, Pakistan.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Pfizer Pakistan | Corporation | Karachi, Pakistan | ||||
| Pfizer (Vienna) | Corporation | Vienna, Austria | ||||
| Genetix Biotherapeutics | Private Equity-Backed | Somerville, MA | ||||
| BioMarin Pharmaceutical | Formerly PE-Backed | San Rafael, CA | ||||
| Sangamo Therapeutics | Formerly VC-backed | Richmond, CA |
Cyclenium Pharma Patents
Cyclenium Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3642399-A1 | Libraries of pyridine-containing macrocyclic compounds and methods of making and using the same | Inactive | 22-Jun-2017 | ||
| EP-3642399-A4 | Libraries of pyridine-containing macrocyclic compounds and methods of making and using the same | Inactive | 22-Jun-2017 | ||
| US-20200190083-A1 | Libraries of pyridine-containing macrocyclic compounds and methods of making and using the same | Inactive | 22-Jun-2017 | ||
| WO-2018232506-A1 | Libraries of pyridine-containing macrocyclic compounds and methods of making and using the same | Inactive | 22-Jun-2017 | ||
| CA-3024071-A1 | Libraries of diverse macrocyclic compounds and methods of making and using the same | Active | 16-May-2016 | C40B30/06 |
Cyclenium Pharma Signals
Cyclenium Pharma FAQs
-
When was Cyclenium Pharma founded?
Cyclenium Pharma was founded in 2013.
-
Where is Cyclenium Pharma headquartered?
Cyclenium Pharma is headquartered in Montreal, Canada.
-
What is the size of Cyclenium Pharma?
Cyclenium Pharma has 5 total employees.
-
What industry is Cyclenium Pharma in?
Cyclenium Pharma’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Cyclenium Pharma a private or public company?
Cyclenium Pharma is a Private company.
-
What is Cyclenium Pharma’s current revenue?
The current revenue for Cyclenium Pharma is .
-
Who are Cyclenium Pharma’s competitors?
Pfizer Pakistan, Pfizer (Vienna), Genetix Biotherapeutics, BioMarin Pharmaceutical, and Sangamo Therapeutics are some of the 53 competitors of Cyclenium Pharma.
-
When was Cyclenium Pharma acquired?
Cyclenium Pharma was acquired on 06-Jun-2023.
-
Who acquired Cyclenium Pharma?
Cyclenium Pharma was acquired by SpiroChem.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process